Dosage regimens for HCV combination therapy comprising BI201335, interferon alpha and ribavirin

Details for Australian Patent Application No. 2010313497 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Haefner, Carla; Steinmann, Gerhard; Stern, Jerry O.; Yong, Chan-Loi

Agent Spruson & Ferguson

Pub. Number AU-A-2010313497

PCT Pub. Number WO2011/053617

Priority 61/256,516 30.10.09 US

Filing date 27 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/7056 (2006.01)

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 March 2012 PCT application entered the National Phase

  PCT publication WO2011/053617 Priority application(s): WO2011/053617

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313504-Wear assembly for excavating equipment

2010313495-Photochromic materials